Iran Sanctions Fuel Drug Shortages, Pushing Patients to Black Market

Iran's pharmaceutical sector is crippled by sanctions, causing shortages of hundreds of drugs, price spikes, and production/import disruptions. Patients are forced to seek black-market alternatives or travel abroad for treatment, raising safety concerns. This highlights the humanitarian impact of sanctions, though the extent of the crisis and its direct attribution to sanctions remain partially inferred.